Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-19-026699
Filing Date
2019-12-20
Accepted
2019-12-20 16:31:07
Documents
5
Effectiveness Date
2019-12-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS defa14a121319_citiuspharma.htm DEFA14A 26316
2 GRAPHIC image_001.jpg GRAPHIC 339994
3 GRAPHIC image_002.jpg GRAPHIC 463592
4 GRAPHIC image_003.jpg GRAPHIC 200138
5 GRAPHIC image_004.jpg GRAPHIC 158158
  Complete submission text file 0001213900-19-026699.txt   1627886
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-38174 | Film No.: 191301997
SIC: 2834 Pharmaceutical Preparations